266 related articles for article (PubMed ID: 25121554)
1. Yeast as a potential vehicle for neglected tropical disease drug discovery.
Denny PW; Steel PG
J Biomol Screen; 2015 Jan; 20(1):56-63. PubMed ID: 25121554
[TBL] [Abstract][Full Text] [Related]
2. The utility of yeast as a tool for cell-based, target-directed high-throughput screening.
Norcliffe JL; Alvarez-Ruiz E; Martin-Plaza JJ; Steel PG; Denny PW
Parasitology; 2014 Jan; 141(1):8-16. PubMed ID: 23611102
[TBL] [Abstract][Full Text] [Related]
3. Yeast-based systems for tropical disease drug discovery.
Balaña-Fouce R; Reguera RM
Expert Opin Drug Discov; 2016; 11(5):429-32. PubMed ID: 26931823
[No Abstract] [Full Text] [Related]
4. High-throughput screening platform for natural product-based drug discovery against 3 neglected tropical diseases: human African trypanosomiasis, leishmaniasis, and Chagas disease.
Annang F; Pérez-Moreno G; García-Hernández R; Cordon-Obras C; Martín J; Tormo JR; Rodríguez L; de Pedro N; Gómez-Pérez V; Valente M; Reyes F; Genilloud O; Vicente F; Castanys S; Ruiz-Pérez LM; Navarro M; Gamarro F; González-Pacanowska D
J Biomol Screen; 2015 Jan; 20(1):82-91. PubMed ID: 25332350
[TBL] [Abstract][Full Text] [Related]
5. Drug discovery for human African trypanosomiasis: identification of novel scaffolds by the newly developed HTS SYBR Green assay for Trypanosoma brucei.
Faria J; Moraes CB; Song R; Pascoalino BS; Lee N; Siqueira-Neto JL; Cruz DJ; Parkinson T; Ioset JR; Cordeiro-da-Silva A; Freitas-Junior LH
J Biomol Screen; 2015 Jan; 20(1):70-81. PubMed ID: 25342146
[TBL] [Abstract][Full Text] [Related]
6. Yeast: bridging the gap between phenotypic and biochemical assays for high-throughput screening.
Denny PW
Expert Opin Drug Discov; 2018 Dec; 13(12):1153-1160. PubMed ID: 30326751
[No Abstract] [Full Text] [Related]
7. Novel trends in high-throughput screening.
Mayr LM; Bojanic D
Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
[TBL] [Abstract][Full Text] [Related]
8. Infectious diseases. Drug developers finally take aim at a neglected disease.
Leslie M
Science; 2011 Aug; 333(6045):933-5. PubMed ID: 21852468
[No Abstract] [Full Text] [Related]
9. Screening Marine Natural Products for New Drug Leads against Trypanosomatids and Malaria.
Álvarez-Bardón M; Pérez-Pertejo Y; Ordóñez C; Sepúlveda-Crespo D; Carballeira NM; Tekwani BL; Murugesan S; Martinez-Valladares M; García-Estrada C; Reguera RM; Balaña-Fouce R
Mar Drugs; 2020 Mar; 18(4):. PubMed ID: 32244488
[TBL] [Abstract][Full Text] [Related]
10. Yeast-based high-throughput screens for discovery of kinase inhibitors for neglected diseases.
Tavella TA; Cassiano GC; Costa FTM; Sunnerhagen P; Bilsland E
Adv Protein Chem Struct Biol; 2021; 124():275-309. PubMed ID: 33632468
[TBL] [Abstract][Full Text] [Related]
11. Overcoming the challenges of drug discovery for neglected tropical diseases: the A·WOL experience.
Johnston KL; Ford L; Taylor MJ
J Biomol Screen; 2014 Mar; 19(3):335-43. PubMed ID: 24241712
[TBL] [Abstract][Full Text] [Related]
12. Understanding and creating value from open source drug discovery for neglected tropical diseases.
Allarakhia M; Ajuwon L
Expert Opin Drug Discov; 2012 Aug; 7(8):643-57. PubMed ID: 22657529
[TBL] [Abstract][Full Text] [Related]
13. Modern Approaches for the Discovery of Anti-Infectious Drugs for the Treatment of Neglected Diseases.
Bellera CL; Sbaraglini ML; Talevi A
Curr Top Med Chem; 2018; 18(5):369-381. PubMed ID: 29741140
[TBL] [Abstract][Full Text] [Related]
14. In silico repositioning of approved drugs for rare and neglected diseases.
Ekins S; Williams AJ; Krasowski MD; Freundlich JS
Drug Discov Today; 2011 Apr; 16(7-8):298-310. PubMed ID: 21376136
[TBL] [Abstract][Full Text] [Related]
15. Neglected tropical disease research: rethinking the drug discovery model.
Bombelles T; Coaker H
Future Med Chem; 2015; 7(6):693-700. PubMed ID: 25996062
[No Abstract] [Full Text] [Related]
16. Current bioanalytical methods for pharmacokinetic studies of drugs used in neglected tropical diseases.
dos Santos Magalhães IR
Bioanalysis; 2014; 6(12):1711-23. PubMed ID: 25077629
[TBL] [Abstract][Full Text] [Related]
17. The importance of patent sharing in neglected disease drug discovery.
Edlin C
Future Med Chem; 2011 Sep; 3(11):1331-4. PubMed ID: 21879838
[No Abstract] [Full Text] [Related]
18. Drugs for neglected diseases: part II.
Kaneko T
Future Med Chem; 2011 Sep; 3(11):1329-30. PubMed ID: 21879837
[No Abstract] [Full Text] [Related]
19. [International Partnership for Therapeutic Drug Development of NTDs by DNDi].
Yamada H; Hirabayashi F; Brünger C
Yakugaku Zasshi; 2016; 136(2):213-22. PubMed ID: 26831796
[TBL] [Abstract][Full Text] [Related]
20. Recent approaches in nanocarrier-based therapies for neglected tropical diseases.
Mengarda AC; Iles B; Longo JPF; de Moraes J
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023 Mar; 15(2):e1852. PubMed ID: 36161523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
